Related references
Note: Only part of the references are listed.Ankylosing spondylitis: correlations between clinical and MRI indices of sacroiliitis activity
P. Zhang et al.
CLINICAL RADIOLOGY (2015)
Soluble CD30 does not predict late acute rejection or safe tapering of immunosuppression in renal transplantation
Lars L. F. G. Valke et al.
TRANSPLANT IMMUNOLOGY (2015)
Update on Ankylosing Spondylitis: Current Concepts in Pathogenesis
Judith A. Smith
CURRENT ALLERGY AND ASTHMA REPORTS (2015)
T lymphocyte subset imbalances in patients contribute to ankylosing spondylitis
Chenggong Wang et al.
EXPERIMENTAL AND THERAPEUTIC MEDICINE (2015)
In rheumatoid arthritis soluble CD30 ligand is present at high levels and induces apoptosis of CD30+T cells
Elisa Tinazzi et al.
IMMUNOLOGY LETTERS (2014)
Increased Bone Marrow (BM) Plasma Level of Soluble CD30 and Correlations with BM Plasma Level of Interferon (IFN)-γ, CD4/CD8 T-Cell Ratio and Disease Severity in Aplastic Anemia
Qingqing Wu et al.
PLOS ONE (2014)
Imbalance in serum soluble CD30/CD3OL and CD40/CD4OL systems are associated with ovarian tumors
Aleksandra Mielczarek-Palacz et al.
HUMAN IMMUNOLOGY (2013)
Elevated serum levels of high mobility group box protein 1 (HMGB1) in patients with ankylosing spondylitis and its association with disease activity and quality of life
Pelin Oktayoglu et al.
RHEUMATOLOGY INTERNATIONAL (2013)
Soluble CD30: A Possible Serum Tumor Marker for Primary Effusion Lymphoma
Manthana Michai et al.
ASIAN PACIFIC JOURNAL OF CANCER PREVENTION (2012)
Serum levels of soluble CD26 and CD30 and their clinical significance in patients with rheumatoid arthritis
Hasan Ulusoy et al.
RHEUMATOLOGY INTERNATIONAL (2012)
Association of serum-soluble CD26 and CD30 levels with asthma, lung function and bronchial hyper-responsiveness at school age
Sami T. Remes et al.
ACTA PAEDIATRICA (2011)
Soluble CD30: A Serum Marker for Epstein-Barr Virus-Associated Lymphoproliferative Diseases
Tanzina Haque et al.
JOURNAL OF MEDICAL VIROLOGY (2011)
Age-dependent changes of serum soluble CD30 concentration in children
Slawomir Chrul et al.
PEDIATRIC TRANSPLANTATION (2011)
Increased Expression of Ganglioside GM1 in Peripheral CD4+T Cells Correlates Soluble Form of CD30 in Systemic Lupus Erythematosus Patients
Lingli Dong et al.
JOURNAL OF BIOMEDICINE AND BIOTECHNOLOGY (2010)
Ankylosing spondylitis: an Australian experience
M. D. Reed et al.
INTERNAL MEDICINE JOURNAL (2008)
The pathogenesis of ankylosing spondylitis
Mohammed F. Shamji et al.
NEUROSURGICAL FOCUS (2008)
The levels of sCD30 and of sCD40L in a group of patients with systemic lupus erythematodes and their diagnostic value
Hana Ciferska et al.
CLINICAL RHEUMATOLOGY (2007)
Pregnancy in patients with rheumatic disease:: anti-inflammatory cytokines increase in pregnancy and decrease post partum
M Ostensen et al.
ANNALS OF THE RHEUMATIC DISEASES (2005)
A Turkish version of the bath ankylosing spondylitis disease activity index: Reliability and validity
Y Akkoc et al.
RHEUMATOLOGY INTERNATIONAL (2005)
CD30 antigen and multiple sclerosis: CD30, an important costimulatory molecule and marker of a regulatory subpopulation of dendritic cells, is involved in the maintenance of the physiological balance between TH1/TH2 immune responses and tolerance - The role of IFN beta-1a in the treatment of multiple sclerosis
P Pellegrini et al.
NEUROIMMUNOMODULATION (2005)
CD30 antigen: not a physiological marker for TH2 cells but an important costimulator molecule in the regulation of the balance between TH1/TH2 response
P Pellegrini et al.
TRANSPLANT IMMUNOLOGY (2003)
Passage from normal mucosa to adenoma and colon cancer: Alteration of normal sCD30 mechanisms regulating TH1/TH2 cell functions
I Contasta et al.
CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS (2003)
CD30 shedding from Karpas 299 lymphoma cells is mediated by TNF-α-converting enzyme
HP Hansen et al.
JOURNAL OF IMMUNOLOGY (2000)
Share Paper
